Medium Term Health Coaching and Life-long Monitoring in Cardiovascular Disease in Norrbotten

Luleå Tekniska Universitet1 site in 1 country741 target enrollmentMarch 2011

ConditionsDiabetes Heart Disease Quality of Life

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Diabetes
Sponsor: Luleå Tekniska Universitet
Enrollment: 741
Locations: 1
Primary Endpoint: SF-36
Status: Completed
Last Updated: 14 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to evaluate whether the introduction of large-scale personalized and technology supported telemonitoring and health coaching interventions produces benefits in terms of health related quality of life, health status and empowerment of patients with a cardiovascular disease. In addition, the trials evaluate the economical and organizational impact of the new services and examine their acceptability by patients and health professionals.

Registry

clinicaltrials.gov

Start Date

March 2011

End Date

September 2011

Last Updated

14 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Luleå Tekniska Universitet

Responsible Party

Principal Investigator

Inger Lindberg

Investigator

Luleå Tekniska Universitet

Eligibility Criteria

Inclusion Criteria

•Diagnosis of arterial hypertension ischemic heart disease,
•atrial fibrillation or other arrhythmia,
•congestive heart failure (study heart disease)
•HbA1C \> 53mmol/mol (study diabetes)
•Age \> 18 years
•Capability of filling in questionnaires in the own language
•Capability to use the devices provided
•Being cognitively able to participate

Exclusion Criteria

Not provided

Outcomes

Primary Outcomes

SF-36

Time Frame: 12 months follow-up

Questionnaire, 36 questions ref Ware, 2000 version 2

Secondary Outcomes

HbA1c (for patients with type-2D) Blood pressure for patient with heart disease(12 months follow-up)
Bloodpressure(12 months follow-up)
Blood lipids(12 months follow-up)
Bodyweight(12 months follow-up)
Smoking habits(12 months follow-up)
Alcohol consumption(12 months follow-up)
SOC-13(12 months follow-up)
EQ-5D(12 monts follow-up)